Get Free Masks at Grocery Stores and Pharmacies This Week Get Free Masks at Grocery Stores and Pharmacies This Week
N95 masks are arriving at grocery stores and pharmacies this week, and consumers will be able to pick them up for free while supplies last.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 27, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Blaine Labs Issues Voluntary Nationwide Recall of RevitaDerm Wound Care Gel Due to Bacterial Contamination
Blaine Labs Company is voluntarily recalling one lot of RevitaDerm Wound Care to the consumer level because a bottle of the 1.0 ounce RevitaDerm Wound Care Gel has been found to be contaminated with Bacillus cereus. Patients who apply the contaminated product to a wound could develop a skin and soft (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 27, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination
Gaia Ethnobotanical, LLC., is voluntarily recalling all kratom (mitragyna speciosa) powder products, with Lot No.: 0102031800 it manufactured, processed, packed, and/or held, between March 18, 2018 to March 30, 2018 to the consumer level. The products have been found by the U.S. Food and Drug Administration ( “FDA”) via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordance to FDA guidelines. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 27, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

HEE launches new independent prescriber training for pharmacists
Health Education England has announced new funded Independent Prescriber courses for pharmacists, which will be available before March 2022. There are places available for both Independent Prescribin (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 27, 2022 Category: Drugs & Pharmacology Source Type: news

Medicine Supply Notification: Paracetamol 120mg and 240mg suppositories
The Department of Health and Social Care has issued a supply notification. Paracetamol 120mg and 240mg suppositories are out of stock until w/c 21st February 2022. Paracetamol 125mg and 250mg supposit (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 27, 2022 Category: Drugs & Pharmacology Source Type: news

Deconex DM Capsule (Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 27, 2022 Category: Drugs & Pharmacology Source Type: news

Association Between Gut Microbiota and Medical Therapies in IBD Association Between Gut Microbiota and Medical Therapies in IBD
This review examines the complex interplay between gut microbiota and inflammatory bowel disease treatment response.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Kimmtrak (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma
Kimmtrak is the first and only FDA approved therapy for the treatment of unresectable or metastatic uveal melanoma (mUM) Kimmtrak is the first T cell receptor (TCR) therapeutic to receive regulatory approval Kimmtrak demonstrated statistically... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 26, 2022 Category: Drugs & Pharmacology Source Type: news

FDA approves tebentafusp-tebn for unresectable or metastatic uveal melanoma
On January 25, 2022, the Food and Drug Administration approved tebentafusp-tebn (Kimmtrak, Immunocore Limited), a bispecific gp100 peptide-HLA-directed CD3 T cell engager, for HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA issues series of guidances under Drug Competition Action Plan
CDER Statement (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments; Draft Guidance for Industry
Generics / User fees (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Drug Monitoring Checker now available through MedicinesComplete
Pharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business, is announcing the release of Drug Monitoring Checker. Available online through MedicinesComplete, Drug Monitoring Che (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 26, 2022 Category: Drugs & Pharmacology Source Type: news

Declomycin (Demeclocycline HCl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2022 Category: Drugs & Pharmacology Source Type: news

Diacomit (Stiripentol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2022 Category: Drugs & Pharmacology Source Type: news

Cibinqo (Abrocitinib Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2022 Category: Drugs & Pharmacology Source Type: news

Paxlovid (Nirmatrelvir Tablets and Ritonavir Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2022 Category: Drugs & Pharmacology Source Type: news

Most COVID ICU Survivors Show Adverse Effects 1 Year Later: Study Most COVID ICU Survivors Show Adverse Effects 1 Year Later: Study
Nearly 60% of former ICU patients reported continuing sickness-related problems at work. Three-fourths reported physical problems, and 26% reported mental problems.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 25, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Pharmacies Turning Away Immunocompromised Seeking 4th COVID Shot Pharmacies Turning Away Immunocompromised Seeking 4th COVID Shot
The Centers for Disease Control and Prevention quietly changed its guidance to allow an extra shot in certain cases, but some pharmacy personnel are confused about who is eligible.Kaiser Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 25, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Tips for Women to Prevent Heart Disease
More women die from heart disease than from any other cause. But women can take action to decrease their risk. The FDA offers many resources to help educate women of all ages about the safe use of FDA-approved drugs and devices for the treatment and prevention of heart disease. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Health Plus Inc. - 616877 - 12/29/2021
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ces llc - 623495 - 01/18/2022
Drug Product/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Aurobindo Pharmaceutical Limited - 618091 - 01/12/2022
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Revising ANDA Labeling Following Revision of the RLD Labeling Guidance for Industry
Generics Revision 1 (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Cormax Ointment (Clobetasol Propionate Ointment) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 25, 2022 Category: Drugs & Pharmacology Source Type: news

Effectiveness of Group and Self-help Hypnotherapy for IBS Effectiveness of Group and Self-help Hypnotherapy for IBS
Are non-individualised approaches to hypnotherapy for irritable bowel syndrome effective in children and adults?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 25, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Two Studies Show Omicron's Immune-Evasive Power, Role of Boosters Two Studies Show Omicron's Immune-Evasive Power, Role of Boosters
Protection is low without boosters, the authors of a new study find. The findings also have immediate implications for the more than 40 countries who have used the CoronaVac vaccine.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 25, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
The FDA revised the authorizations for two monoclonal antibody treatments to limit their use to only when the patient is likely to have been infected with or exposed to a variant that is susceptible of these treatments. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 24, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Untitled Letters 2022
These letters are supplied by the CDER Freedom of Information Office and only covers Office of Prescription Drug Promotion's untitled letters. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 24, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Nucala (mepolizumab) 40 mg Prefilled Syringe for Children with Severe Eosinophilic Asthma
This approval allows for at-home administration in patients 6-11 years old with severe eosinophilic asthma. PHILADELPHIA, PA, 24 January 2022 -- GlaxoSmithKline plc (GSK) today announced that the US Food and Drug Administration (FDA) has... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 24, 2022 Category: Drugs & Pharmacology Source Type: news

Health, Social Care and Sport Committee Inquiry into Alternative pathways into Primary Care
The Royal Pharmaceutical Society (RPS) in Scotland today welcomes the Health, Social Care and Sport Committee inquiry into alternative pathways into primary care. Pharmacists provide face to face hea (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 24, 2022 Category: Drugs & Pharmacology Source Type: news

Helping you put your inclusion and wellbeing pledge into action
We’ve created a set of ideas to help individuals, teams and organisation put our inclusion and wellbeing pledge into action. They range from practical short-term steps like knowing where to sig (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 24, 2022 Category: Drugs & Pharmacology Source Type: news

Ryaltris (Olopatadine Hydrochloride and Mometasone Furoate Monohydrate Nasal Spray) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 24, 2022 Category: Drugs & Pharmacology Source Type: news

Low Vaccine Uptake in Black Communities Often an Access Issue: Study Low Vaccine Uptake in Black Communities Often an Access Issue: Study
Data suggest that Black people are equally or more willing than White people to get a vaccine, which may mean access is the bigger problem, researchers say.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 22, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19
The FDA took two actions to expand the use of the antiviral drug Veklury (remdesivir) to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease in places such as skilled nursing facilities, home healthcare settings and outpatient facilities. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 21, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Public Meeting: Identification of Concepts and Terminology for Multi-Component Biomarkers - 03/23/2022
The FDA Center for Drug Evaluation and Research and the FDA Biomarker Working Group will convene a virtual workshop on March 23-24, 1-3 PM (EST) entitled “Identification of Concepts and Terminology for Multi-Component Biomarkers”. The workshop is intended to develop multi-component biomarker concepts and terminology to identify areas of conceptual (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 21, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Collecting and Providing 702(b) Portions of FDA Official Samples
- Questions and Answers (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 21, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

U.S. FDA Approves Second Indication for Skyrizi (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis
NORTH CHICAGO, Ill., Jan. 21, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved Skyrizi® (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 21, 2022 Category: Drugs & Pharmacology Source Type: news

FDA Approves Veklury (remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression
Approval Based on Phase 3 Data Showing Veklury Significantly Reduced Risk of Hospitalization By 87% Compared with Placebo NIH Guidelines Recommend Veklury for the Treatment of Non-Hospitalized Patients at High Risk FDA Expands Pediatric... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 21, 2022 Category: Drugs & Pharmacology Source Type: news

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
NEW YORK& MIAMI--(BUSINESS WIRE) January 21, 2022 -- Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 21, 2022 Category: Drugs & Pharmacology Source Type: news

Alma LeVant Hayden's Contributions to Regulatory Science
Virtual exhibit about former Director of the Spectrophotometry Branch, Alma Hayden (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 20, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

COVID at 2 Years: Preparing for a Different'Normal'COVID at 2 Years: Preparing for a Different'Normal '
Experts hope for a better summer and envision an endemic status ahead where health systems will include COVID-19 as part of the yearly respiratory burden.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 20, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

How the Pandemic Led to Disarray ― and Discovery How the Pandemic Led to Disarray ― and Discovery
In the scramble to tackle the virus in real time, entrenched scientific and medical processes were challenged, sometimes leading to mixed results.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 20, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

The Virus Within: How Misinformation Made the Pandemic Worse The Virus Within: How Misinformation Made the Pandemic Worse
Based in lack of trust that is often fanned by politicians, the media, and others, misinformation has not only caused arguments but arguably has also cost many lives.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 20, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

The Pandemic Has Changed Us, Permanently The Pandemic Has Changed Us, Permanently
Over the past 2 years, Americans have made many changes to how they live, work, play, worship ― and manage their health. Many experts think some of these changes are here to stay.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 20, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

COVID-19 Survivors and Experts Share Pandemic'Silver Linings'COVID-19 Survivors and Experts Share Pandemic'Silver Linings '
' Benefit finding'is a skill among some of the more resilient people whose lives have been upended by COVID-19, and experts explain how it can help others.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 20, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

COVID-19 Families and Experts Share Pandemic'Silver Linings'COVID-19 Families and Experts Share Pandemic'Silver Linings '
' Benefit finding'is a skill among some of the more resilient people whose lives have been upended by COVID-19, and experts explain how it can help others.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 20, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

' Artificial Pancreas' Life-Changing in Kids With Type 1 Diabetes'Artificial Pancreas' Life-Changing in Kids With Type 1 Diabetes
A semi-automated insulin delivery system using proprietary software improved time in target blood glucose range in young children aged 5 years, on average, with type 1 diabetes.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 19, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

FDA warns about rare but severe lung inflammation with Ibrance, Kisqali, and Verzenio for breast cancer
. FDA approvs new warnings about this risk to the prescribing information and Patient Package Insert for the entire class of these cyclin-dependent kinase 4/6. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 19, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Fat Burners Zone Issues Voluntary Nationwide Recall of Zero Xtreme Due to Presence of Undeclared Sibutramine
Fat Burners Zone is voluntarily recalling 1 lot of Zero Xtreme, capsules to the consumer level. FDA analysis has found Zero Xtreme to be tainted with sibutramine. Sibutramine is an appetite suppressant that was withdrawn from the U.S. market due to safety concerns. The presence of Sibutramine in Zer (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 19, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news